Advanced Search
Contact | Corporate | Help

Masitinib in Patients With Primary Progressive or Relapse-free Secondary Multiple Sclerosis

Sponsors:
  • AB Science
Phases:
  • Phase II
  • Phase III
IndicationsAcronym:
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Relapse Free
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: masitinib
  • Drug: placebo
Enrollment:
450

Additional information about NCT01433497.


SourceSolution © 2008-2012